Prognostic Value of Neutrophil-Lymphocyte Ratio in Cardiogenic Shock: A Cohort Study.
Aged
Aged, 80 and over
Biomarkers
/ blood
Cohort Studies
Databases, Factual
Female
Humans
Inflammation
/ pathology
Kaplan-Meier Estimate
Leukocyte Count
/ methods
Lymphocyte Count
/ methods
Lymphocytes
/ pathology
Male
Middle Aged
Neutrophils
/ pathology
Prognosis
Proportional Hazards Models
ROC Curve
Retrospective Studies
Shock, Cardiogenic
/ immunology
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
18 May 2020
18 May 2020
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
7
2
2021
Statut:
epublish
Résumé
BACKGROUND Inflammation plays an important part in the pathogenesis of cardiogenic shock (CGS). Whether the neutrophil-lymphocyte ratio (NLR), an integrated biomarker of inflammation, is associated with the outcome of CGS patients remains unknown. This retrospective cohort study was performed to identify the utility of using NLR among patients with CGS. MATERIAL AND METHODS Data were extracted from the MIMIC database. We applied smooth curve fitting to define the NLR cutoff values. The primary outcome was 30-day mortality. Cox proportional hazards models, subgroup analysis, and receiver operator characteristic (ROC) curve analysis were performed. RESULTS A total of 1470 CGS patients were extracted, among which 801 (54.5%) were men. The mean age of the population was 70.37 years. An inverse U-shaped relationship was observed between NLR and mortality in CGS patients, with the highest risk being at values ranging from 9.4 to 15. For the primary outcome of 30-day mortality, the adjusted HR (95% CI) values of the middle tertile (NLR 9.4-15) and the upper tertile (NLR >15) were 1.47 (1.14, 1.88) and 1.22 (0.94, 1.57) compared with the reference of lower tertile (NLR <9.4). ROC curve analysis showed that NLR had a more sensitive prognostic value in predicting 30-day mortality of CGS than the neutrophil or lymphocyte percentage alone (0.660 vs. 0.540, 0.549). CONCLUSIONS An inverse U-shaped curve was presented between NLR and the mortality of CGS. NLR seemed to be a readily available and independent prognostic biomarker for patients with CGS. The prognostic value of NLR was more sensitive than the neutrophil or lymphocyte percentage alone, but not as good as SOFA or SAPSII score.
Identifiants
pubmed: 32418983
pii: 922167
doi: 10.12659/MSM.922167
pmc: PMC7251960
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e922167Références
Biomed Res Int. 2018 Nov 11;2018:2703518
pubmed: 30534554
Am J Cardiol. 2010 Aug 15;106(4):470-6
pubmed: 20691303
Crit Care. 2014 Feb 14;18(1):407
pubmed: 24524810
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):45-52
pubmed: 28838261
J Cancer Res Clin Oncol. 2012 Dec;138(12):2009-16
pubmed: 22772951
Mol Immunol. 2019 Jan;105:213-223
pubmed: 30554082
J Cardiovasc Thorac Res. 2014;6(1):35-41
pubmed: 24753830
Clin Chim Acta. 2008 Sep;395(1-2):27-31
pubmed: 18498767
Am J Cardiol. 2006 Apr 1;97(7):993-6
pubmed: 16563903
Surgery. 2017 Oct;162(4):752-765
pubmed: 28688518
Crit Care Med. 2006 Aug;34(8):2035-42
pubmed: 16775569
J Am Coll Cardiol. 2005 May 17;45(10):1638-43
pubmed: 15893180
Am Heart J. 1994 Mar;127(3):674-82
pubmed: 8122618
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Lancet. 2006 Jul 8;368(9530):157-69
pubmed: 16829300
Int Immunopharmacol. 2019 Sep;74:105692
pubmed: 31228818
Am J Cardiol. 2008 Sep 15;102(6):653-7
pubmed: 18773982
Clin Res Cardiol. 2012 May;101(5):375-84
pubmed: 22212516
Circulation. 2003 Sep 9;108(10):1184-90
pubmed: 12925454
Shock. 2014 Jul;42(1):22-6
pubmed: 24827392
Crit Care Med. 2013 Nov;41(11):2484-91
pubmed: 23939355
Crit Care Med. 2013 Nov;41(11):2644-7
pubmed: 24162677
BMJ. 2014 Jan 23;348:g14
pubmed: 24458585
Curr Protoc Bioinformatics. 2003 Feb;Chapter 9:Unit9.2
pubmed: 18428713
Am J Cardiol. 2008 Jun 1;101(11):1537-40
pubmed: 18489929
Am Heart J. 2007 Nov;154(5):995-1002
pubmed: 17967611
Circulation. 2017 Oct 17;136(16):e232-e268
pubmed: 28923988
Am J Cardiol. 1997 Mar 15;79(6):812-4
pubmed: 9070569
Medicine (Baltimore). 2015 Oct;94(42):e1702
pubmed: 26496280
Sci Data. 2016 May 24;3:160035
pubmed: 27219127
Cardiol Clin. 2018 Feb;36(1):53-61
pubmed: 29173681
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Tumour Biol. 2011 Apr;32(2):317-24
pubmed: 21052888
J Coll Physicians Surg Pak. 2017 Jan;27(1):4-7
pubmed: 28292359